Pfizer Inc. (PFE.F)

EUR 25.0

(-0.48%)

Net Income Summary of Pfizer Inc.

  • Pfizer Inc.'s latest annual net income in 2023 was 2.11 Billion USD , down -93.25% from previous year.
  • Pfizer Inc.'s latest quarterly net income in 2024 Q2 was 41 Million USD , down -98.68% from previous quarter.
  • Pfizer Inc. reported an annual net income of 31.37 Billion USD in 2022, up 42.74% from previous year.
  • Pfizer Inc. reported an annual net income of 21.97 Billion USD in 2021, up 139.97% from previous year.
  • Pfizer Inc. reported a quarterly net income of 41 Million USD for 2024 Q2, down -98.68% from previous quarter.
  • Pfizer Inc. reported a quarterly net income of -3.36 Billion USD for 2023 Q4, down -41.44% from previous quarter.

Annual Net Income Chart of Pfizer Inc. (2023 - 1989)

Historical Annual Net Income of Pfizer Inc. (2023 - 1989)

Year Net Income Net Income Growth
2023 2.11 Billion USD -93.25%
2022 31.37 Billion USD 42.74%
2021 21.97 Billion USD 139.97%
2020 9.15 Billion USD -42.85%
2019 16.02 Billion USD 43.71%
2018 11.15 Billion USD -47.66%
2017 21.3 Billion USD 195.34%
2016 7.21 Billion USD 3.68%
2015 6.95 Billion USD -23.81%
2014 9.13 Billion USD -58.49%
2013 22 Billion USD 51.02%
2012 14.56 Billion USD 45.58%
2011 10 Billion USD 21.22%
2010 8.25 Billion USD -4.4%
2009 8.63 Billion USD 6.55%
2008 8.1 Billion USD -0.44%
2007 8.14 Billion USD -57.89%
2006 19.33 Billion USD 139.29%
2005 8.07 Billion USD -28.86%
2004 11.35 Billion USD 190.73%
2003 3.9 Billion USD -57.2%
2002 9.12 Billion USD 17.18%
2001 7.78 Billion USD 109.02%
2000 3.72 Billion USD 17.21%
1999 3.17 Billion USD -5.13%
1998 3.35 Billion USD 51.42%
1997 2.21 Billion USD 14.72%
1996 1.92 Billion USD 22.64%
1995 1.57 Billion USD 21.14%
1994 1.29 Billion USD 97.48%
1993 657.5 Million USD -18.92%
1992 810.9 Million USD 12.3%
1991 722.1 Million USD -9.87%
1990 801.2 Million USD 17.63%
1989 681.1 Million USD -13.93%

Peer Net Income Comparison of Pfizer Inc.

Name Net Income Net Income Difference
Bayer Aktiengesellschaft -2.94 Billion EUR 172.05%
Sanofi 5.4 Billion EUR 60.759%